Debi wrote an interesting post today on Here’s a quick excerpt Swiss drugmaker Roche said on Monday phase III trial data showed that Avastin combined with gemcitabine-cisplatin chemotherapy improved the time patients lived without lung cancer progressing.
September 15th, 2008
Posted in